Skip Nav Destination
Issues
1 August 2007
-
Cover Image
Cover Image
Gius and colleagues determined gene expression signatures of cervical carcinogenesis using cDNA microarrays to analyze RNA from laser-captured microdissected epithelium and underlying stroma from normal cervix, graded cervical intraepithelial neoplasia (CIN 1-3), cancer, and patient-matched normal cervical tissues. In this model, the CIN 1 transition coincides with a proproliferative/immunosuppression gene signature in the epithelium that probably represents the epithelial response to HPV infection. The CIN 2 transition coincides with a proangiogenic signature suggesting a cooperative signaling interaction between stroma and tumor cells. Finally, the CIN 3 and squamous cell carcinoma antigen transition coincide with a proinvasive gene signature that may be a response to epithelial tumor cell overcrowding. The yellow and red horizontal line in the middle of the figure represents the basement membrane that separates the epithelium and stromal compartments. Genes coded in dark red represent validated genes with increased expression whereas dark blue represents validated genes with decreased expression. Additional genes are also depicted in the model; gray signifies previously identified host and viral genes, and light red or light blue denotes genes that increase or decrease, respectively, from the microarray data but are not yet validated. For details, see the article by Gius and colleagues on page 7113 of this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Reviews
Priority Reports
Metastasis-Associated Protein 1 Transgenic Mice: A New Model of Spontaneous B-Cell Lymphomas
Rozita Bagheri-Yarmand; Seetharaman Balasenthil; Anupama E. Gururaj; Amjad H. Talukder; Yui-Hsi Wang; Ju Han Lee; Young Sik Kim; Xinaglan Zhang; Daniel M. Jones; L. Jeffrey Medeiros; L. Clifton Stephens; Yong-Jun Liu; Norman Lee; Insun Kim; Rakesh Kumar
Molecular Biology, Pathobiology, and Genetics
Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates
David Gius; Margo C. Funk; Eric Y. Chuang; Sheng Feng; Phyllis C. Huettner; Loan Nguyen; C. Matthew Bradbury; Mark Mishra; Shuping Gao; Barbara M. Buttin; David E. Cohn; Matthew A. Powell; Neil S. Horowitz; Bradford P. Whitcomb; Janet S. Rader
Cell, Tumor, and Stem Cell Biology
Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2
Christine E. Horak; Jong Heun Lee; Abdel G. Elkahloun; Mathieu Boissan; Sylvie Dumont; Tara K. Maga; Sandrine Arnaud-Dabernat; Diane Palmieri; William G. Stetler-Stevenson; Marie-Lise Lacombe; Paul S. Meltzer; Patricia S. Steeg
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma: Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption
François Lamoureux; Peggy Richard; Yohann Wittrant; Séverine Battaglia; Paul Pilet; Valérie Trichet; Frédéric Blanchard; François Gouin; Bruno Pitard; Dominique Heymann; Françoise Redini
Monoclonal Antibody Blockade of the Human Eag1 Potassium Channel Function Exerts Antitumor Activity
David Gómez-Varela; Esther Zwick-Wallasch; Hendrik Knötgen; Araceli Sánchez; Thore Hettmann; Dmitri Ossipov; Rüdiger Weseloh; Constanza Contreras-Jurado; Mike Rothe; Walter Stühmer; Luis A. Pardo
Immunology
Targeting Human γδ T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer
Francesco Dieli; David Vermijlen; Fabio Fulfaro; Nadia Caccamo; Serena Meraviglia; Giuseppe Cicero; Andrew Roberts; Simona Buccheri; Matilde D'Asaro; Nicola Gebbia; Alfredo Salerno; Matthias Eberl; Adrian C. Hayday
Combined Natural Killer T-Cell–Based Immunotherapy Eradicates Established Tumors in Mice
Michele W.L. Teng; Jennifer A. Westwood; Phillip K. Darcy; Janelle Sharkey; Moriya Tsuji; Richard W. Franck; Steven A. Porcelli; Gurdyal S. Besra; Kazuyoshi Takeda; Hideo Yagita; Michael H. Kershaw; Mark J. Smyth
Endocrinology
Clinical Research
Mouse Models of Prostate Adenocarcinoma with the Capacity to Monitor Spontaneous Carcinogenesis by Bioluminescence or Fluorescence
Chun-Peng Liao; Chen Zhong; Gohar Saribekyan; James Bading; Ryan Park; Peter S. Conti; Rex Moats; Anton Berns; Wei Shi; Zongxiang Zhou; Alexander Yu Nikitin; Pradip Roy-Burman
Epidemiology and Prevention
Advertisement